These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 43211)

  • 1. Injectable non-occlusive chemical contraception in the male-I.
    Misro M; Guha SK; Singh H; Mahajan S; Ray AR; Vasudevan P
    Contraception; 1979 Nov; 20(5):467-73. PubMed ID: 43211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mode of contraception using polymeric hydrogels. I.
    Singh H; Vasudevan P; Misro M; Ray AR; Guha SK
    J Biomed Mater Res; 1982 Jan; 16(1):3-9. PubMed ID: 7056760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
    Koul V; Srivastav A; Guha SK
    Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of HFMC injection of various concentrations on patency of vas deferens and resumption of fertility in rats].
    Xiang D; Luo Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):379-83. PubMed ID: 1814816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anionic polymeric hydrogels on spermatozoa motility.
    Singh H; Jabbal MS; Ray AR; Vasudevan P
    Biomaterials; 1984 Sep; 5(5):307-9. PubMed ID: 6487714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
    Sethi N; Srivastava RK; Nath D; Singh RK
    J Med Primatol; 1991; 20(2):89-93. PubMed ID: 1865485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RISUG: an intravasal injectable male contraceptive.
    Lohiya NK; Alam I; Hussain M; Khan SR; Ansari AS
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S63-72. PubMed ID: 25673546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contraceptive development for the future].
    Zatuchni GI
    Contracept Fertil Sex (Paris); 1984 Jun; 12(6):769-79. PubMed ID: 12313176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
    Guha SK
    Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future prospects in male contraception.
    Netw Res Triangle Park N C; 1987; 8(4):8. PubMed ID: 12269106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.